Molecular Immunology & Cellular Microbiology Laboratory
In context of the Indian sub-continent, Tuberculosis and Visceral Leishmaniasis are dreadful infectious diseases caused by Mycobacterium tuberculosis and Leishmania donovani respectively. The advent of extreme drug resistance has aggravated the situation. The search for newer molecular targets as well as alternative therapeutic strategies is clearly evident.
Using CRISPR/Cas9 mediated genome editing our lab tries to have a thorough understanding of the host factors governing parasite pathogenesis. We are looking into the roles of phosphatases and kinases in mediating parasite survival. Biochemical assays are being set-up for the functional characterization of macrophage factors phosphorylated by mycobacteria secreted virulence factors. Functional characterization and adaptive resistance mechanism studies are carried out for an essential Leishmania enzyme. Besides, the role of host factors that enable controlled phagosome maturation and hinder macrophage apoptosis in context of mycobacteria and those allowing efficient promastigote to amastigote differentiation as well as factors dampening macrophage proliferation but promoting amastigote proliferation in context of Leishmania are being studied.
We are also trying to envisage into host-directed immunomodulatory therapeutics against mycobacterial infection that would help overcome the pathogen-induced classical macrophage activation block and thereby re-enable them to kill the parasite. Drug repurposing approaches against Leishmania specific enzymes using tri-cyclic anti-depressants are also being carried out whose application through the creation of reticulo-endothelial blockade would be tried out.
We are also engaged in developing non-invasive, rapid, low-cost, point-of-care screening platform for latent TB and rapid, point of care diagnostics for drug resistant TB.
-
Resolving the polycistronic aftermath: Essential role of topoisomerase IA in preventing R-loops in Leishmania by Das P., Hazra A. , Saha S. , Roy S. , Mukherjee M. , Majumder H. K., Bosedasgupta S. Journal of Biological Chemistry 300 107162-107180 (2024)
-
A bumpy ride of Mycobacterial Phagosome maturation: roleplay of Coronin1 through Cofilin1 and cAMP by Saha S., Hazra A. , Ghatak D. , Singh A. V., Roy S. , Bosedasgupta S. Frontiers in Immunology 12 - (2021)
-
ESX secretion system: the gatekeepers of mycobacterial survivability and pathogenesis by Roy S., Ghatak D. , Bosedasgupta S. European Journal of Microbiology and Immunology 10 202-209 (2020)
-
It takes two to tango : role of neglected macrophage manipulators Coronin 1 and Protein kinase G in mycobacterial pathogenesis by Saha S., Das P. , Bosedasgupta S. Frontiers Cellular and Infection Microbiology 10 582563- (2020)
-
Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis. by Bosedasgupta S., Pieters J. Seminars in Immunopathology 40 577-591 (2018)
-
The ultimate fate determinants of drug induced cell-death mechanisms in Trypanosomatids by Das P., Saha S. , Bosedasgupta S. Int J Parasitol Drugs Drug Resist. 15 81-91 (2020)
Principal Investigator
- Development of a rapid, non-invasive, point-of-care biosensor to detect drug resistance status in TB affected population INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR)
- Elucidating the role of mycobacteria secreted Protein Kinase G (PknG) mediated phosphorylation of macrophage Proteasome Modulator 9 (PSMD9) and its implication in hindering macrophage apoptosis. Indian Council of Medical Research (ICMR)
- ENLIGHTEN: Easy Non-invasive detection of Latent tuberculosis Infection in Geographically High Tuberculosis ENdemic areas Indian Council of Medical Research, Dept. of Health Research, Ministry of Health and Family Welfare
- Establishing a State-of the-Art Hybrid BSLIII Facility at IIT Kharagpur to Facilitate Fundamental Research and Development of Diagnostics and Therapeutics Against Class III Pathogen Caused Viral and Bacterial Diseases Science and Engineering Research Board (SERB)
- Harnessing the Drug Repurposing potential of LipoNor (Liposomal
Norclomipramine) as a promising anti-leishmanial INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR)
Ph. D. Students
Arjun Sankhla
Area of Research: Novel Diagnostics in Tuberculosis
Debayan Das
Area of Research: Infectious Disease Biology
Saborni Biswas
Area of Research: Host-pathogen interaction
Sadhana Roy
Area of Research: Molecular Immunology and Cellular Microbiology
Sayantani Datta
Area of Research: Molecular Immunology and Cellular Microbiology